Literature DB >> 17873317

The interplay of insulin resistance and beta-cell dysfunction involves the development of type 2 diabetes in Chinese obeses.

Jie Hong1, Wei-Qiong Gu, Yi-Fei Zhang, Yi-Sheng Yang, Chun-Fang Shen, Min Xu, Xiao-Ying Li, Wei-Qing Wang, Guang Ning.   

Abstract

Type 2 diabetes mellitus (T2DM) is a heterogeneous disorder characterized by defects in insulin secretion and action and obesity plays an important role in the deterioration of glucose metabolism. In the present study we evaluated the degree of insulin resistance and first-phase insulin secretion of beta-cell in obese subjects with normal glucose tolerance (NGT), impaired glucose tolerance (IGT), and T2DM in Chinese. A total of 220 subjects underwent standard 75 g oral glucose tolerance test (OGTT) and insulin-modified frequently sampled intravenous glucose tolerance test (FSIGT). Insulin sensitivity index (S I) was assessed by the reduced sample number (n = 12) of Bergman's minimal model method with FSIGT. Insulin secretion capacities were determined by the insulinogenic index (I 30 min - I 0 min)/(G 30 min - G 0 min) in OGTT and the acute insulin response to glucose (AIR) in FSIGT. The disposition index (DI), the product of AIR and S I was used to determine whether AIR was adequate to compensate for insulin resistance. The S I in healthy lean control group was significantly higher than that in NGT, IGT, and T2DM group, but there was no significant difference among NGT, IGT, and T2DM group. The AIR in NGT group was significantly greater than that in control group, but then it was progressively decreased in IGT and T2DM group. The value of DI in control group was significantly higher than that in those three abnormal groups, and was decreased from NGT to IGT and T2DM group with significant difference. It indicates that obese subjects with different glucose tolerances have a similar degree of insulin resistance but differ in insulin secretion in Chinese Han population.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17873317     DOI: 10.1007/s12020-007-0002-2

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  18 in total

1.  Relationships among age, proinsulin conversion, and beta-cell function in nondiabetic humans.

Authors:  Andreas Fritsche; Alexander Madaus; Norbert Stefan; Otto Tschritter; Elke Maerker; Anna Teigeler; Hans Häring; Michael Stumvoll
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

2.  Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women.

Authors:  Frank B Hu; Tricia Y Li; Graham A Colditz; Walter C Willett; JoAnn E Manson
Journal:  JAMA       Date:  2003-04-09       Impact factor: 56.272

3.  Glucose intolerance and aging: evidence for tissue insensitivity to insulin.

Authors:  R A Defronzo
Journal:  Diabetes       Date:  1979-12       Impact factor: 9.461

4.  Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function.

Authors:  S E Kahn; R L Prigeon; D K McCulloch; E J Boyko; R N Bergman; M W Schwartz; J L Neifing; W K Ward; J C Beard; J P Palmer
Journal:  Diabetes       Date:  1993-11       Impact factor: 9.461

5.  The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus.

Authors:  C Weyer; C Bogardus; D M Mott; R E Pratley
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

6.  Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development.

Authors:  C Weyer; P A Tataranni; C Bogardus; R E Pratley
Journal:  Diabetes Care       Date:  2001-01       Impact factor: 19.112

7.  The visceral adiposity syndrome in Japanese-American men.

Authors:  W Y Fujimoto; S L Abbate; S E Kahn; J E Hokanson; J D Brunzell
Journal:  Obes Res       Date:  1994-07

8.  Insulin sensitivity and acute insulin response in African-Americans, non-Hispanic whites, and Hispanics with NIDDM: the Insulin Resistance Atherosclerosis Study.

Authors:  S M Haffner; G Howard; E Mayer; R N Bergman; P J Savage; M Rewers; L Mykkänen; A J Karter; R Hamman; M F Saad
Journal:  Diabetes       Date:  1997-01       Impact factor: 9.461

9.  Increased insulin resistance and insulin secretion in nondiabetic African-Americans and Hispanics compared with non-Hispanic whites. The Insulin Resistance Atherosclerosis Study.

Authors:  S M Haffner; R D'Agostino; M F Saad; M Rewers; L Mykkänen; J Selby; G Howard; P J Savage; R F Hamman; L E Wagenknecht
Journal:  Diabetes       Date:  1996-06       Impact factor: 9.461

10.  Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased beta-cell function.

Authors:  M Chen; R N Bergman; G Pacini; D Porte
Journal:  J Clin Endocrinol Metab       Date:  1985-01       Impact factor: 5.958

View more
  11 in total

1.  Evaluation of a risk factor scoring model in screening for undiagnosed diabetes in China population.

Authors:  Jian-jun Dong; Neng-jun Lou; Jia-jun Zhao; Zhong-wen Zhang; Lu-lu Qiu; Ying Zhou; Lin Liao
Journal:  J Zhejiang Univ Sci B       Date:  2011-10       Impact factor: 3.066

2.  Translational Modeling and Simulation in Supporting Early-Phase Clinical Development of New Drug: A Learn-Research-Confirm Process.

Authors:  Dongyang Liu; Yi Zhang; Ji Jiang; John Choi; Xuening Li; Dalong Zhu; Dawei Xiao; Yanhua Ding; Hongwei Fan; Li Chen; Pei Hu
Journal:  Clin Pharmacokinet       Date:  2017-08       Impact factor: 6.447

3.  New evidence for an association between liver enzymes and pancreatic islet β-cell dysfunction in young obese patients.

Authors:  Li Wang; Juanjuan Zhang; Bokai Wang; Yuwen Zhang; Jie Hong; Yifei Zhang; Weiqing Wang; Weiqiong Gu
Journal:  Endocrine       Date:  2013-04-03       Impact factor: 3.633

4.  Elevated A1C is associated with impaired early-phase insulin secretion rather than insulin resistance in Koreans at high risk for developing diabetes.

Authors:  Tae Nyun Kim; Man Sik Park; Seong Keon Lee; Sae Jeong Yang; Kwan Woo Lee; Moonsuk Nam; Moon Suk Nam; Yong Soo Park; Jeong-Taek Woo; Jeong Taek Woo; Young Seol Kim; Sei Hyun Baik
Journal:  Endocrine       Date:  2012-05-03       Impact factor: 3.633

Review 5.  Differential Effects of Amount, Intensity, and Mode of Exercise Training on Insulin Sensitivity and Glucose Homeostasis: A Narrative Review.

Authors:  Katherine A Collins; Leanna M Ross; Cris A Slentz; Kim M Huffman; William E Kraus
Journal:  Sports Med Open       Date:  2022-07-14

6.  Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study.

Authors:  Adam G Tabák; Markus Jokela; Tasnime N Akbaraly; Eric J Brunner; Mika Kivimäki; Daniel R Witte
Journal:  Lancet       Date:  2009-06-08       Impact factor: 79.321

7.  Effects of exercise training intensity on pancreatic beta-cell function.

Authors:  Cris A Slentz; Charles J Tanner; Lori A Bateman; Michael T Durheim; Kim M Huffman; Joseph A Houmard; William E Kraus
Journal:  Diabetes Care       Date:  2009-07-10       Impact factor: 19.112

8.  Insulin sensitivity and first-phase insulin secretion in obese Chinese with hyperglycemia in 30 and/or 60 min during glucose tolerance tests.

Authors:  Jie Hong; Yi-Fei Zhang; Wei-qiong Gu; Yu-wen Zhang; Yu-xia Su; Zhen-ni Chi; Wei-qing Wang; Xiao-ying Li; Guang Ning
Journal:  Endocrine       Date:  2008-11-01       Impact factor: 3.633

Review 9.  Clinical utility and patient considerations in the use of the sitagliptin-metformin combination in Chinese patients.

Authors:  Qiang Du; Yan-Jun Wang; Sheng Yang; Ping Han
Journal:  Patient Prefer Adherence       Date:  2015-02-09       Impact factor: 2.711

10.  Trajectories of glycaemia, insulin sensitivity and insulin secretion in South Asian and white individuals before diagnosis of type 2 diabetes: a longitudinal analysis from the Whitehall II cohort study.

Authors:  Adam Hulman; Rebecca K Simmons; Eric J Brunner; Daniel R Witte; Kristine Færch; Dorte Vistisen; Satoyo Ikehara; Mika Kivimaki; Adam G Tabák
Journal:  Diabetologia       Date:  2017-04-13       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.